IL2 and autoimmune disease: This concept is supported by observations showing that polymorphisms altering IL-2 signaling in humans are associated with autoimmune diseases, including type 1 diabetes, celiac disease, multiple sclerosis (MS), Graves’ disease, Sjögren’s syndrome, and rheumatoid arthritis (120, 121, 122, 123).